论文部分内容阅读
研究选取我院在2014年9月~2015年9月收治的70例糖尿病患者,作为观察组,同期选择70例健康者作为对照组,对两组研究对象行血清C肽联合糖化血红蛋白检验,观察两组研究对象的检验指标(Hb A1c、FBG、血清C肽),并将所得结果进行对比分析研究。结果:在Hb A1c、FBG、餐后2h血糖值、血清C肽检验指标方面,观察组和对照组具有显著差异,差异具有统计学意义(P<0.05)。结论:对患者行血清C肽联合糖化血红蛋白检验,若发现Hb A1c等指标出现异常,可将其作为判断胰岛素分泌功能出现异常重要指标,并对临床诊断糖尿病提供重要参考价值,因此该方法值得在临床上推广和使用。
The study selected 70 patients with diabetes mellitus treated in our hospital from September 2014 to September 2015 as the observation group and 70 healthy people as the control group during the same period.The serum C-peptide combined with HbA1c were detected in two groups Two groups of test indicators (Hb A1c, FBG, serum C-peptide), and the results were compared and analyzed. Results: There were significant differences in Hb A1c, FBG, 2h postprandial blood glucose and serum C peptide test indicators between the observation group and the control group (P <0.05). Conclusions: Serum C-peptide combined with HbA1c was tested in patients. If Hb A1c and other abnormalities were found, it could be used as an important index to judge the abnormality of insulin secretion and provide an important reference value for clinical diagnosis of diabetes. Therefore, Clinical promotion and use.